Vanda Pharmaceuticals
Utility Patents

Last updated:

List of all Vanda Pharmaceuticals patents 31 in total

Status Patent
Grant
Utility: Method of treatment with tradipitant External link
Filling date: 6 Sep 2025 Issue date: 10 May 2022
Grant
Utility: Treatment of circadian rhythm disorders External link
Filling date: 6 Sep 2025 Issue date: 29 Mar 2022
Grant
Utility: Method of treatment External link
Filling date: 6 Sep 2025 Issue date: 8 Mar 2022
Grant
Utility: Genetic markers for enhancing efficacy of antipsychotic treatment with iloperidone External link
Filling date: 6 Sep 2025 Issue date: 4 Jan 2022
Grant
Utility: Liquid tasimelteon formulations and methods of use thereof External link
Filling date: 6 Sep 2025 Issue date: 21 Dec 2021
Grant
Utility: Highly purified pharmaceutical grade tasimelteon External link
Filling date: 6 Sep 2025 Issue date: 21 Dec 2021
Grant
Utility: Method of treatment External link
Filling date: 6 Sep 2025 Issue date: 12 Oct 2021
Grant
Utility: Treatment of circadian rhythm disorders External link
Filling date: 6 Sep 2025 Issue date: 17 Aug 2021
Grant
Utility: Cancer treatment External link
Filling date: 6 Sep 2025 Issue date: 3 Aug 2021
Grant
Utility: Treatment of schizophrenia External link
Filling date: 6 Sep 2025 Issue date: 27 Jul 2021
Grant
Utility: Method of treatment External link
Filling date: 6 Sep 2025 Issue date: 25 May 2021
Grant
Utility: Iloperidone for the treatment of schizophrenia External link
Filling date: 6 Sep 2025 Issue date: 27 Apr 2021
Grant
Utility: Treatment of circadian rhythm disorders External link
Filling date: 6 Sep 2025 Issue date: 20 Apr 2021
Grant
Utility: Treatment of circadian rhythm disorders External link
Filling date: 6 Sep 2025 Issue date: 16 Mar 2021
Grant
Utility: Iloperidone metabolite for use in the treatment of psychiatric disorders External link
Filling date: 6 Sep 2025 Issue date: 29 Dec 2020
Grant
Utility: Highly purified pharmaceutical grade tasimelteon External link
Filling date: 6 Sep 2025 Issue date: 10 Nov 2020
Grant
Utility: Use of tradipitant in motion sickness External link
Filling date: 6 Sep 2025 Issue date: 3 Nov 2020
Grant
Utility: Method of treatment with tradipitant External link
Filling date: 6 Sep 2025 Issue date: 15 Sep 2020
Grant
Utility: Method of treatment External link
Filling date: 6 Sep 2025 Issue date: 19 May 2020
Grant
Utility: Method of treatment External link
Filling date: 6 Sep 2025 Issue date: 7 Apr 2020
Grant
Utility: Treatment of circadian rhythm disorders External link
Filling date: 6 Sep 2025 Issue date: 7 Apr 2020
Grant
Utility: Highly purified pharmaceutical grade tasimelteon External link
Filling date: 6 Sep 2025 Issue date: 7 Apr 2020
Grant
Utility: Method of predicting a predisposition to QT prolongation External link
Filling date: 6 Sep 2025 Issue date: 25 Feb 2020
Grant
Utility: Method of predicting a predisposition to QT prolongation External link
Filling date: 6 Sep 2025 Issue date: 25 Feb 2020
Grant
Utility: Method of predicting a predisposition to QT prolongation External link
Filling date: 6 Sep 2025 Issue date: 18 Feb 2020
Grant
Utility: Method of predicting a predisposition to QT prolongation External link
Filling date: 6 Sep 2025 Issue date: 18 Feb 2020
Grant
Utility: Method of treatment based on polymorphisms of the KCNQ1 gene External link
Filling date: 6 Sep 2025 Issue date: 18 Feb 2020
Grant
Utility: Method of treatment with tradipitant External link
Filling date: 6 Sep 2025 Issue date: 5 Nov 2019
Grant
Utility: Treatment of circadian rhythm disorders External link
Filling date: 6 Sep 2025 Issue date: 22 Oct 2019
Grant
Utility: Iloperidone for the treatment of schizophrenia External link
Filling date: 6 Sep 2025 Issue date: 15 Oct 2019
Grant
Utility: Method of treatment External link
Filling date: 6 Sep 2025 Issue date: 13 Aug 2019

Showing 1 to 31 of 31 patents.